Benjamin F. Edwards & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$16.2M Buy
111,097
+5,742
+5% +$854K 0.29% 105
2024
Q1
$16.7M Buy
105,355
+663
+0.6% +$106K 0.3% 95
2023
Q4
$16.4M Buy
104,692
+5,420
+5% +$831K 0.33% 90
2023
Q3
$15.5M Sell
99,272
-4,376
-4% -$722K 0.59% 31
2023
Q2
$17.2M Buy
103,648
+1,298
+1% +$209K 0.65% 25
2023
Q1
$15.9M Buy
102,350
+464
+0.5% +$74.9K 0.66% 24
2022
Q4
$18M Buy
101,886
+2,159
+2% +$373K 0.81% 20
2022
Q3
$16.3M Sell
99,727
-9,358
-9% -$1.58M 0.82% 22
2022
Q2
$19.4M Buy
109,085
+4,619
+4% +$823K 0.94% 17
2022
Q1
$18.5M Sell
104,466
-84
-0.1% -$14.3K 0.83% 19
2021
Q4
$17.9M Buy
104,550
+2,286
+2% +$374K 0.8% 21
2021
Q3
$16.5M Buy
102,264
+2,209
+2% +$377K 0.83% 17
2021
Q2
$16.5M Buy
100,055
+1,833
+2% +$303K 0.84% 18
2021
Q1
$16.1M Buy
98,222
+1,573
+2% +$255K 0.87% 13
2020
Q4
$15.2M Buy
96,649
+1,398
+1% +$206K 0.9% 17
2020
Q3
$14.2M Buy
95,251
+408
+0.4% +$60.4K 0.95% 15
2020
Q2
$13.3M Sell
94,843
-2,539
-3% -$370K 0.97% 18
2020
Q1
$12.8M Sell
97,382
-9,052
-9% -$1.28M 1.09% 15
2019
Q4
$15.5M Buy
106,434
+5,545
+5% +$752K 1.09% 12
2019
Q3
$13.1M Sell
100,889
-935
-0.9% -$123K 1.02% 11
2019
Q2
$14.2M Buy
101,824
+4,508
+5% +$624K 1.19% 10
2019
Q1
$13.6M Buy
97,316
+5,316
+6% +$712K 1.23% 10
2018
Q4
$11.9M Buy
92,000
+16,953
+23% +$2.36M 1.23% 11
2018
Q3
$10.4M Buy
75,047
+965
+1% +$128K 0.98% 15
2018
Q2
$8.99M Sell
74,082
-16,078
-18% -$2.01M 0.89% 19
2018
Q1
$11.6M Buy
90,160
+14,192
+19% +$1.92M 1.18% 14
2017
Q4
$10.6M Sell
75,968
-3,499
-4% -$487K 1.11% 21
2017
Q3
$10.3M Buy
79,467
+422
+0.5% +$55.9K 1.24% 16
2017
Q2
$10.5M Sell
79,045
-203
-0.3% -$25.9K 1.37% 13
2017
Q1
$9.87M Sell
79,248
-4,693
-6% -$561K 1.45% 10
2016
Q4
$9.67M Buy
83,941
+606
+0.7% +$70K 1.58% 6
2016
Q3
$9.84M Buy
83,335
+16,793
+25% +$2.04M 1.74% 7
2016
Q2
$8.07M Buy
66,542
+1,300
+2% +$148K 1.57% 9
2016
Q1
$7.06M Sell
65,242
-381
-0.6% -$39.4K 1.46% 13
2015
Q4
$6.74M Buy
65,623
+1,238
+2% +$125K 1.45% 12
2015
Q3
$6.01M Sell
64,385
-1,554
-2% -$150K 1.32% 10
2015
Q2
$6.43M Buy
65,939
+13,992
+27% +$1.4M 1.28% 13
2015
Q1
$5.23M Buy
51,947
+2,648
+5% +$269K 1.1% 20
2014
Q4
$5.16M Buy
49,299
+2,667
+6% +$281K 1.2% 14
2014
Q3
$4.97M Buy
46,632
+248
+0.5% +$25.7K 1.24% 13
2014
Q2
$4.85M Buy
46,384
+365
+0.8% +$36.9K 1.23% 12
2014
Q1
$4.52M Buy
46,019
+2,414
+6% +$224K 1.24% 16
2013
Q4
$3.99M Buy
43,605
+2,108
+5% +$194K 1.35% 12
2013
Q3
$3.6M Buy
41,497
+1,582
+4% +$142K 1.33% 13
2013
Q2
$3.43M Buy
+39,915
New +$3.39M 1.37% 12

Other funds holding JNJ

Benjamin F. Edwards & Company's JNJ Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Johnson & Johnson (JNJ) stake by 5.5% in Q2 2024, buying an estimated $854K and bringing the position to 111,097 shares worth $16.2M. The position accounts for 0.29% of the portfolio, ranked #105.

Benjamin F. Edwards & Company first reported a position in JNJ in Q2 2013 and has held it in 45 quarters since. The position peaked at $19.4M in Q2 2022. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Benjamin F. Edwards & Company held 111,097 shares of Johnson & Johnson worth $16.2M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 5,742 Johnson & Johnson shares in Q2 2024, an estimated $854K.
  • Johnson & Johnson made up 0.29% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #105 holding.
  • Benjamin F. Edwards & Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 45 quarters since.
  • Benjamin F. Edwards & Company's Johnson & Johnson position peaked at $19.4M in Q2 2022.
  • 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.